THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

New drug firm limits prompt fears of falloff in medical meetings in city

By Liz Kowalczyk
Globe Staff / January 24, 2009

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Boston's status as a popular destination for medical industry meetings - which generate tens of millions of dollars in revenue for hotels, restaurants, and the state - is at risk because of new regulations restricting financial relationships between pharmaceutical companies and doctors, according to industry executives. (Full article: 993 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass